Skip to main content

Animations

MJFF Publications

3091 - 3100 of 6451 Results
Title
Year
  • Year
  • 2021
  • 2022
  • 2016
  • 2023
  • 2019
  • 2019
  • 2016
  • 2017
  • 2024
  • 2019
  • Summary Details
    OPEN
    Title: Effects of Gocovri (Amantadine) Extended Release Capsules on Non-Motor Symptoms in Patients with Parkinson’s Disease and Dyskinesia
    Journal Name: Neurology and Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1007/s40120-021-00246-3
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Patient Experience in Early-Stage Parkinson’s Disease: Using a Mixed Methods Analysis to Identify Which Concepts Are Cardinal for Clinical Trial Outcome Assessment
    Journal Name: Neurology and Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1007/s40120-022-00375-3
    Citation Count: 44
  • Summary Details
    OPEN
    Title: Machine Learning Interface for Medical Image Analysis
    Journal Name: Journal of Digital Imaging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: apache-2.0
    DOI - Digital Object Identifier: 10.1007/s10278-016-9910-0
    Citation Count: 68
  • Summary Details
    OPEN
    Title: Anxiety Change After Dopamine Therapy in Parkinson Disease is Independent of Motor Improvement
    Journal Name: The American Journal of Geriatric Psychiatry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jagp.2023.09.001
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.jalz.2019.04.007
    Citation Count: 40
  • Summary Details
    OPEN
    Title: A novel approach to study markers of dopamine signaling in peripheral immune cells
    Journal Name: Journal of Immunological Methods
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jim.2019.112686
    Citation Count: 23
  • Summary Details
    OPEN
    Title: White matter hyperintensities are more highly associated with preclinical Alzheimer's disease than imaging and cognitive markers of neurodegeneration
    Journal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.dadm.2016.03.001
    Citation Count: 93
  • Summary Details
    OPEN
    Title: Beyond L-DOPA: hope for Parkinson’s treatment and diagnosis
    Journal Name: EBioMedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.ebiom.2017.09.009
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Deep learning‐based BMI inference from structural brain MRI reflects brain alterations following lifestyle intervention
    Journal Name: Human Brain Mapping
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/hbm.26595
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Regional neuropathology distribution and verbal fluency impairments in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.05.014
    Citation Count: 26
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.